Neurosense Therapeutics Ltd (NRSN) — Working Capital to Net Assets Ratio
Neurosense Therapeutics Ltd (NRSN) has a Working Capital to Net Assets ratio of 124.7% as of June 2025. Working capital of $-647.00K (current assets of $1.56 Million minus current liabilities of $2.20 Million) is measured against net assets of $-519.00K. A higher ratio indicates strong short-term liquidity financed by the equity base. See Neurosense Therapeutics Ltd (NRSN) net asset quality to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Neurosense Therapeutics Ltd Working Capital to Net Assets (2019–2024)
This chart shows how Neurosense Therapeutics Ltd's Working Capital to Net Assets ratio has evolved across 6 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 124.7%, reflecting working capital of $-647.00K against net assets of $-519.00K USD. Check Neurosense Therapeutics Ltd tangible equity quality to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Neurosense Therapeutics Ltd (2019–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Neurosense Therapeutics Ltd from 2019 to 2024, covering 6 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see market value of Neurosense Therapeutics Ltd.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 93.3% | $2.41 Million | $2.58 Million | $4.40 Million | $1.99 Million | ▲ +62.6 pp |
| 2023 | 30.7% | $-543.00K | $-1.77 Million | $2.92 Million | $3.46 Million | ▼ -69.9 pp |
| 2022 | 100.6% | $5.66 Million | $5.62 Million | $7.38 Million | $1.73 Million | ▼ -19.4 pp |
| 2021 | 120.1% | $10.81 Million | $9.01 Million | $11.41 Million | $597.00K | ▲ +27.7 pp |
| 2020 | 92.4% | $609.00K | $659.00K | $729.00K | $120.00K | ▼ -3.0 pp |
| 2019 | 95.4% | $876.00K | $918.00K | $913.00K | $37.00K | — |